BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Activity
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

70 hedge funds and large institutions have $370M invested in Bellicum Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 7 closing their positions.

Holders
70
Holders Change
+3
Holders Change %
+4.48%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
27
Reduced
19
Closed
7
Calls
$815K
Puts
$1.24M
Net Calls
-$428K
Net Calls Change
-$242K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$68.5M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$17.4M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.28M
4
BIT
4
BlackRock Institutional Trust
California
$7.89M
5
BFA
5
BlackRock Fund Advisors
California
$18.8M

Top Sellers

1
FCMI
1
Foresite Capital Management III
California
$0
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$44.5M
3
QF
3
QVT Financial
New York
$7.74M
4
KCM
4
Kennedy Capital Management
Missouri
$5.22M
5
Goldman Sachs
5
Goldman Sachs
New York
$247K
Name Market Value Shares Shares
Change 		Shares
Change %
CFA
76
CT Financial Advisors
Pennsylvania
– – -450 Closed
HR
77
Howe & Rusling
New York
– – -28 Closed
Citadel Advisors
78
Citadel Advisors
Florida
– – – –
1 2 3
4